Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON26893
NL-OMON26893
Recruiting
Not Applicable

ormal fetal neurodevelopment; healthy control population as a comparison for fetuses with a congenital heart disease – observational cohort study

eiden University Medical Center0 sites70 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCongenital heart diseaseIntra-uterine neurodevelopmental disorders

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital heart diseaseIntra-uterine neurodevelopmental disorders
Sponsor
eiden University Medical Center
Enrollment
70
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
eiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • •Singleton pregnancy
  • •\- Normal second trimester ultrasound (absence of abnormalities on ultrasound)
  • •\- No use of alcohol, drugs or other psychoactive substances during pregnancy
  • •\- Age \= 18 years
  • •\- Gestational age 18\-36 weeks

Exclusion Criteria

  • •\- Obstetric history of intra\-uterine growth restriction or intra\-uterine fetal demise
  • •\- Serious underlying maternal medical condition
  • •\- Use of teratogenic medication during pregnancy
  • •\- Congenital abnormalities detected in the first year of life

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
ormal fetal neurodevelopment: healthy control population to compare with fetuses with a congenital heart disease
NL-OMON49553eids Universitair Medisch Centrum70
Active, not recruiting
Not Applicable
When to deliver small babies between 32 and 37 weeksFetal growth restrictionPregnancy and Childbirth
ISRCTN76016200Imperial College London638
Completed
Not Applicable
Brain Development after prenatal growth retardation: effects of growth hormone treatmentSmall for Gestational Age (SGA), brain developmentNutritional, Metabolic, EndocrineBrain development
ISRCTN20279720Pfizer B.V. (The Netherlands)110
Not yet recruiting
Not Applicable
Brain development after prenatal growth retardation; effects of growth hormone treatmentsmall for gestational age / intra uterine growth failure1002111210010273
NL-OMON30243Vrije Universiteit Medisch Centrum110
Completed
Not Applicable
ong-term neurodevelopmental outcome after perinatal arterial ischemic strokeperinatal arterial ischemic stroke (PAIS)neonatal stroke1000796310028920
NL-OMON55959niversitair Medisch Centrum Utrecht50